A new Northwestern Medicine study has demonstrated how differences in neural activity within the brain’s olfactory and orbital cortices cause people to perceive the same odors differently, according to findings published in Nature Neuroscience.
Donald Lloyd-Jones, MD, ScM, the Eileen M. Foell Professor, has announced that he will be stepping down as chair of the Department of Preventive Medicine at the end of this academic year, after 15 years of service in the role.
A multi-institutional team of investigators including Northwestern University scientists has received $45 million to fast-track the development of a first-of-its-kind implant to sense and treat cancer.
Northwestern Medicine scientists have identified how one gene connects glioblastoma stem cell self-renewal to microglia immunosuppression in glioblastoma, according to a new study published in Nature Immunology.
Northwestern Simulation has introduced a new curricular experience to help internal medicine residents improve skills needed for the high-acuity, high-intensity scenario of leading and managing cardiac arrests in the hospital.
Northwestern Medicine investigators have uncovered new mechanisms by which iron deficiency inhibits cell growth and proliferation in eukaryotic cells, findings that could improve the understanding of cancer growth and the development of targeted cancer therapies.
In 2022, Feinberg established research into social determinants of health as a priority. To better understand the impact of social determinants of health, Feinberg investigators have been leading studies that provide new insights into how a person’s neighborhood can positively or negatively affect their health.
Robert A. Lamb, PhD, professor emeritus of Microbiology-Immunology and of Molecular Biosciences and an internationally recognized authority on influenza, died September 2. He was 72.
Bethany Ekesa, associate director of Feinberg’s Sponsored Project and Research Catalysts (SPARC) team, was selected as the recipient of the 2023 Jean E. Shedd University Citizenship Award.
A combination immunotherapy treatment of nivolumab plus ipilimumab was associated with no improvement in survival for advanced cancers other than melanoma, when compared to nivolumab alone, according to a recent Northwestern Medicine meta-analysis published in JAMA Oncology.
